| IV-012 Pooneh Soltantabar Elranatamab Exposure-Safety Analysis in Patients with Relapse or Refractory Multiple Myeloma: Insights from MagnetisMM Studies Thursday 15:00-16:30 |
| IV-012 Pooneh Soltantabar Elranatamab Exposure-Safety Analysis in Patients with Relapse or Refractory Multiple Myeloma: Insights from MagnetisMM Studies Thursday 15:00-16:30 |